Analysis of the Impact of the Presence of Phylum Cyanobacteria in the Microbiome of Patients with Breast Cancer on Their Prognosis
Open Access
- 7 December 2022
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (24) , 7272
Abstract
Cyanobacterial blooms caused by Cyanobacteria adversely affect the health of the people living in their vicinity. We elucidated the effect of Cyanobacteria in patients with breast cancer. The serum microbiome of the patients with breast cancer was analyzed using NGS. Serologic tests were performed to analyze the association between the factors affecting the liver function of patients with breast cancer and the amount of Cyanobacteria. In addition, the recurrent-free survival of patients with breast cancer according to the abundance of Cyanobacteria was analyzed. The abundance of Cyanobacteria tended to be correlated with the serological results related to liver function. A high abundance of Cyanobacteria seemed to be more related to late-stage breast cancer. A high recurrent-free survival was related to a low abundance of Cyanobacteria. Even though no toxicity study was conducted, this study demonstrates the impact of phylum Cyanobacteria on the prognosis of patients with breast cancer. Thus, the abundance of Cyanobacteria in the microbiome can help predict the prognosis of patients with breast cancer.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2021R1A2C1014094)
This publication has 33 references indexed in Scilit:
- The power of small changes: Comprehensive analyses of microbial dysbiosis in breast cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2019
- The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD)Cellular and Molecular Life Sciences, 2019
- Optimal management of luminal breast cancer: how much endocrine therapy is long enough?Therapeutic Advances in Medical Oncology, 2018
- Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver diseaseMicrobiome, 2017
- Alterations of the human gut microbiome in liver cirrhosisNature, 2014
- Environmental conditions that influence toxin biosynthesis in cyanobacteriaEnvironmental Microbiology, 2012
- Seasonal Dynamics of Microcystis spp. and Their Toxigenicity as Assessed by qPCR in a Temperate ReservoirMarine Drugs, 2011
- Tumor Promoters - Microcystin-LR, Nodularin and TNF-α and Human Cancer DevelopmentAnti-Cancer Agents in Medicinal Chemistry, 2011
- CyanobacteriaCurrent Biology, 2009
- Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of GuamProceedings of the National Academy of Sciences, 2003